BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12758176)

  • 1. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
    Abujamra AL; Faller DV; Ghosh SK
    Virology; 2003 May; 309(2):294-305. PubMed ID: 12758176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.
    Ghosh SK; Faller DV
    J Virol; 1999 Jun; 73(6):4931-40. PubMed ID: 10233955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
    Ghosh SK; Roy-Burman P; Faller DV
    J Virol; 2000 Oct; 74(20):9742-8. PubMed ID: 11000248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.
    Abujamra AL; Spanjaard RA; Akinsheye I; Zhao X; Faller DV; Ghosh SK
    Virology; 2006 Feb; 345(2):390-403. PubMed ID: 16289658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.
    Finstad SL; Prabhu S; Rulli KR; Levy LS
    Virol J; 2004 Sep; 1():3. PubMed ID: 15507152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of endogenous feline leukemia virus long terminal repeats and adjoining regions.
    Berry BT; Ghosh AK; Kumar DV; Spodick DA; Roy-Burman P
    J Virol; 1988 Oct; 62(10):3631-41. PubMed ID: 2843665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
    Hwang YW; Yoo NK; Yang HM; Choi SY
    Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
    Faller DV; Weng H; Choi SY
    Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.
    Pantginis J; Beaty RM; Levy LS; Lenz J
    J Virol; 1997 Dec; 71(12):9786-91. PubMed ID: 9371646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases.
    Jackson ML; Haines DM; Misra V
    Vet Microbiol; 1996 Dec; 53(3-4):213-25. PubMed ID: 9008333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
    Prabhu S; Lobelle-Rich PA; Levy LS
    Virology; 1999 Oct; 263(2):460-70. PubMed ID: 10544118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus.
    Elder JH; Mullins JI
    J Virol; 1983 Jun; 46(3):871-80. PubMed ID: 6304347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity.
    Faller DV; Weng H; Graves DT; Choi SY
    J Cell Physiol; 1997 Aug; 172(2):240-52. PubMed ID: 9258345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.
    Athas GB; Lobelle-Rich P; Levy LS
    J Virol; 1995 Jun; 69(6):3324-32. PubMed ID: 7745680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
    Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
    J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding.
    Weng H; Choi SY; Faller DV
    J Biol Chem; 1995 Jun; 270(23):13637-44. PubMed ID: 7775415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.